z-logo
Premium
Leukotriene B 4 ‐ induced changes in vascular permeability are mediated by neutrophil release of heparin‐binding protein (HBP/CAP37/azurocidin)
Author(s) -
Di Gennaro Antonio,
Kenne Ellinor,
Wan Min,
Soehnlein Oliver,
Lindbom Lennart,
Haeggström Jesper Z.
Publication year - 2009
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.08-121277
Subject(s) - vascular permeability , heparin , leukotriene b4 , leukotriene , permeability (electromagnetism) , chemistry , immunology , medicine , inflammation , biochemistry , membrane , asthma
In humans, heparin‐binding protein (HBP) and the potent chemotactic lipid leukotriene B 4 (LTB 4 ) are important mediators of innate immune reponses. Here we show that human neutrophils (PMNs) challenged with LTB 4 (30 s to 5 min) release HBP as determined by Western blot analysis. This response peaks at 100 nM of agonist and is mediated by the BLT1 receptor. Proteinphosphatase‐1 (30 μM) and wortmannin (0.5 μM) block the LTB 4 ‐mediated HBP release from PMNs, which suggests involvement of the 1‐phosphatidylinositol 3‐kinase intracellular pathway during degranulation. Furthermore, postsecretory supernatants from LTB 4 ‐stimulated PMNs induce intracellular calcium mobilization in endothelial cells in vitro and increase in vascular permeability in vivo , as assessed in a mouse model of pleurisy. Selective removal of HBP from the supernatant significantly reduces these activities attributing a key role to HBP in the LTB 4 ‐induced change in vascular permeability. This lipid‐protein axis could offer novel opportunities for pharmacological intervention in key steps of the vascular response to inflammation.—Di Gennaro, A., Kenne, E., Wan, M., Soehnlein, O., Lindbom, L., Haeggstrom, J.Z. Leukotriene B4‐induced changes in vascular permeability are mediated by neutrophil release of heparinbinding protein (HBP/CAP37/azurocidin). FASEB J. 23, 1750–1757 (2009)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here